by Amne Borghol, PharmD, BCPS, BCGP; Michael Aucoin, PharmD; Ifeanyichukwu Onor, PharmD, BCPS; Dana Jamero, PharmD, BCOP; and Fadi Hawawini, DO, CMD Drs. Borghol, Onor, and Jamero are with the
by Emily Leppien, PharmD, BCPS; Kimberly Mulcahy, PharmD, BCPS, BCPP; Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP; Eileen Trigoboff, RN, PMHCNS-BC, DNS, DABFN; and Lewis Opler, MD, PhD† Drs.
by Khurshid A. Khurshid, MD, FAASM Dr. Khurshid is Clinical Associate Profressor and Chief of the Neuromodulation and Sleep Disorders Program in the Department of Psychiatry at the University of
by Swapnajeet Sahoo, MD; Susanta Kumar Padhy, MD; Neha Singla, MD; and Aakanksha Singh, MD Drs. Sahoo, Singla, and Singh are Senior Residents and Dr. Padhy is Associate Professor in
by Steven D. Targum, MD; Christopher Murphy, PhD; Jibran Khan, BA; Laura Zumpano, BA; Mark Whitlock, PhD; Arthur A. Simen, MD, PhD; and Brendon Binneman, MD† Drs. Targum and Murphy
This ongoing column explores off-label or emerging treatment options, drug development trends, and theoretical concepts in the field of neuroscience. by Anja Srienc, PhD, MD; Puneet Narang, MD; Simrat Sarai,
by Donna Vanderpool, MBA, JD Ms. Vanderpool is Vice President, Risk Management at PRMS, Inc. in Arlington, Virginia. Innov Clin Neurosci. 2018;15(3–4):47–51 Funding: No funding was provided for the preparation
Innov Clin Neurosci. 2018;15(3–4):11–14 Dear Editor: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with a rapid progression, affecting motor neurons in the brain and spinal cord, ultimately leading to
Innov Clin Neurosci. 2018;15(3–4):11–14 Dear Editor: Recently, Iwaku et al1 reported a detailed case of olanzapine-related acute-onset Type 1 diabetes with ketoacidosis.1 They concluded that olanzapine sometimes can cause sudden
Innov Clin Neurosci. 2018;15(3–4):11–14 Dear Editor: Schizophrenia is a chronic and progressive psychiatric disorder requiring long-term treatment with antipsychotics. The use of long-acting injectable antipsychotics (LAI) has been shown to
by Amanda K. Kitten, PharmD; Sarah A. Hallowell, PharmD; Stephen Saklad, PharmD, BCPP; and Kirk E. Evoy, PharmD, BCACP, BC-ADM, CTTS Drs. Kitten, Hallowell, Saklad, and Evoy are with the
by Sandeep Grover, MD; Aditya Somani, MD; Neeru Sahni, MD; Sahil Mehta, DM; Swati Choudhary, MBBS; Rahul Kumar Chakravarty, MBBS; and Anju Moni Rabha, MBBS Drs. Grover, Somani, Sahni, Mehta,
by Jessica Robinson-Papp, MD, MS; Mary Catherine George, MM, PhD; Alexandra Nmashie, MD; Donald Weisz, PhD; and David M. Simpson, MD Drs. Robinson-Papp, George, Nmashie and Simpson are with the
by Carola Mullins, MD; Jorge Miranda, MS; Hugo Sandoval, PhD; Luis Ramos-Duran, MD; and Silvina B. Tonarelli, MD Drs. Mullins , Sandoval, and Ramos-Duran are with the Department of Radiology,
by J. Cara Pendergrass, PhD; Steven D. Targum, MD; and John E. Harrison, BSc (hons), PhD, Cpsychol, CSCI Drs. Pendergrass and Targum are with Bracket Global and Clintara LLC, A
by Jeffrey Guina, MD, and Cathryn Guina, BSN, RN, CNRN Dr. Jeffrey Guina is with the Department of Psychiatry, Wright State University Boonshoft School of Medicine in Dayton, Ohio, and
by Ann L. McNary, JD Ms. McNary is a Senior Risk Manager at PRMS, Inc. Innov Clin Neurosci. 2017;15(1–2):49–51 This ongoing column is dedicated to providing information to our readers
Dear Editor: Pneumocephalus was first described in 1866, and the term was coined in 1914.[1] It is also known as a pneumatocele or intracerebral aerocele and may be classified as
Neuroscience is the Next Oncology
by Michael D. Ehlers, MD, PhD Dr. Ehlers is with Biogen in Cambridge, Massachusetts. Innov Clin Neurosci. 2018;15(3–4):15–16 Funding: No funding was received for the preparation of this article. Disclosures:
Read More